# ET-blockade and Exercise-induced Vascular Adaptations in T2DM

> **NCT01779609** · PHASE4 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 19 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Bosentan
- **DRUG:** Placebo
- **BEHAVIORAL:** Exercise

## Key facts

- **NCT ID:** NCT01779609
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2016-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01779609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01779609, "ET-blockade and Exercise-induced Vascular Adaptations in T2DM". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01779609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*